Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04149496 · ClinicalTrials.gov registry record · NA

IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer

A NA study of Polycystic Ovary Syndrome, sponsored by Bruce Rose, MD.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04149496 is a NA study of Polycystic Ovary Syndrome that is actively recruiting participants, run by Bruce Rose, MD. The registered enrollment target is 300 participants, below the 17,248-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04149496, a NA study of Polycystic Ovary Syndrome, is actively recruiting participants, sponsored by Bruce Rose, MD.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

A protocol was developed to improve pregnancy results after IVM compared to results from studies in the literature. Differences from most published protocols include the use of the Steiner-Tan needle to optimize oocyte environment during oocyte retrieval, use of oral medications and very low doses of FSH, and delayed embryo transfer during subsequent warmed cryo-preserved embryo transfer. Eligible patient have a PCO pattern in their ovaries during transvaginal ultrasound.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT in vitro maturation of oocytes

Study Locations (1)

Florida

  • Brown Fertility - Jacksonville

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-05-10
Est. Completion 2023-12-31
Phase NA

Sponsor

Bruce Rose, MD

1 total trials

What the Registry Record Tells You About NCT04149496

The ClinicalTrials.gov registry entry for NCT04149496 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,248-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (98% lower). The listed sponsor is Bruce Rose, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which in vitro maturation of oocytes is the first listed.

NCT04149496 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04149496 about?

NCT04149496 is a clinical study titled "IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer". A protocol was developed to improve pregnancy results after IVM compared to results from studies in the literature. Differences from most published protocols include the use of the Steiner-Tan needle to optimize oocyte environment during oocyte retrieval, use of oral medications and very low doses o...

What is the current status of trial NCT04149496?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-05-10. Estimated completion is 2023-12-31.

What conditions does trial NCT04149496 study?

This clinical trial studies the following conditions: Polycystic Ovary Syndrome.

What interventions are being tested in trial NCT04149496?

The interventions under investigation include: in vitro maturation of oocytes (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT04149496?

This trial is sponsored by Bruce Rose, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04149496 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Polycystic Ovary Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.